• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连接肝脏葡萄糖和脂质代谢的信号传导机制。

Signalling mechanisms linking hepatic glucose and lipid metabolism.

作者信息

Weickert M O, Pfeiffer A F H

机构信息

Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.

出版信息

Diabetologia. 2006 Aug;49(8):1732-41. doi: 10.1007/s00125-006-0295-3. Epub 2006 May 23.

DOI:10.1007/s00125-006-0295-3
PMID:16718463
Abstract

Fatty liver and hepatic triglyceride accumulation are strongly associated with obesity, insulin resistance and type 2 diabetes, and are subject to nutritional influences. Hepatic regulation of glucose and lipid homeostasis is influenced by a complex system of hormones, hormonally regulated signalling pathways and transcription factors. Recently, considerable progress has been made in elucidating molecular pathways and potential factors that are affected in insulin-resistant states. In this review we discuss some of the key factors that are involved in both the regulation of glucose and lipid metabolism in the liver. Understanding the molecular network that links hepatic lipid accumulation and impaired glucose metabolism may provide targets for dietary or pharmacological interventions.

摘要

脂肪肝和肝脏甘油三酯蓄积与肥胖、胰岛素抵抗及2型糖尿病密切相关,并受营养因素影响。肝脏对葡萄糖和脂质稳态的调节受激素、激素调节信号通路及转录因子组成的复杂系统影响。近来,在阐明胰岛素抵抗状态下受影响的分子途径和潜在因素方面取得了显著进展。在本综述中,我们讨论了一些参与肝脏葡萄糖和脂质代谢调节的关键因素。了解将肝脏脂质蓄积与葡萄糖代谢受损联系起来的分子网络,可能为饮食或药物干预提供靶点。

相似文献

1
Signalling mechanisms linking hepatic glucose and lipid metabolism.连接肝脏葡萄糖和脂质代谢的信号传导机制。
Diabetologia. 2006 Aug;49(8):1732-41. doi: 10.1007/s00125-006-0295-3. Epub 2006 May 23.
2
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease.胆汁酸与胰岛素抵抗:对非酒精性脂肪性肝病治疗的启示
J Dig Dis. 2009 May;10(2):85-90. doi: 10.1111/j.1751-2980.2009.00369.x.
3
Nuclear transcription factors and lipid homeostasis in liver.肝脏中的核转录因子与脂质稳态
Chin Med J (Engl). 2007 Dec 20;120(24):2290-6.
4
Comment on: Weickert MO, Pfeiffer AFH (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741.
Diabetologia. 2007 Feb;50(2):493-4; author reply 495-6. doi: 10.1007/s00125-006-0550-7. Epub 2006 Dec 6.
5
Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.肝脂肪变性:代谢综合征的一个介质。来自动物模型的经验教训。
Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):644-9. doi: 10.1161/01.ATV.0000116217.57583.6e. Epub 2004 Jan 8.
6
Insulin signaling to hepatic lipid metabolism in health and disease.胰岛素信号在健康和疾病中的肝脂质代谢作用。
Crit Rev Biochem Mol Biol. 2011 Jun;46(3):200-15. doi: 10.3109/10409238.2011.562481. Epub 2011 Apr 5.
7
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.肝脏脂质蓄积:血糖调节激素失调的原因及后果
J Endocrinol. 2017 Jul;234(1):R1-R21. doi: 10.1530/JOE-16-0513. Epub 2017 Apr 20.
8
LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing.脂质稳态的Luxury:核激素受体、转录调控与胆固醇感知的统一
Mol Interv. 2002 Apr;2(2):78-87. doi: 10.1124/mi.2.2.78.
9
Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.肝脏X受体的激活促进脂质积累,但不改变人骨骼肌细胞中的胰岛素作用。
Diabetologia. 2006 May;49(5):990-9. doi: 10.1007/s00125-006-0140-8. Epub 2006 Feb 16.
10
Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.核受体在脂质诱导的胰岛素抵抗中对胰岛素分泌调节的作用
Biochem Soc Trans. 2008 Oct;36(Pt 5):891-900. doi: 10.1042/BST0360891.

引用本文的文献

1
Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management.优化骨骼肌质量作为肥胖管理的关键策略。
Metabolites. 2025 Feb 1;15(2):85. doi: 10.3390/metabo15020085.
2
Potential alternative and novel biomarkers for paediatric MAFLD: exploratory evidence from a Chinese cohort.儿童代谢功能障碍相关脂肪性肝病的潜在替代生物标志物和新型生物标志物:来自中国队列的探索性证据。
BMC Gastroenterol. 2025 Jan 22;25(1):28. doi: 10.1186/s12876-025-03619-2.
3
Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing's syndrome.

本文引用的文献

1
Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.疾病机制:选择性抑制11β-羟基类固醇脱氢酶1型作为代谢综合征的一种新疗法。
Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):92-9. doi: 10.1038/ncpendmet0023.
2
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.激酶LKB1介导肝脏中的葡萄糖稳态及二甲双胍的治疗作用。
Science. 2005 Dec 9;310(5754):1642-6. doi: 10.1126/science.1120781. Epub 2005 Nov 24.
3
Fatty acid regulation of hepatic gene transcription.
皮质醇对肾上腺偶发瘤和库欣综合征患者肝脏脂肪及代谢健康的影响。
Endocrine. 2025 Jan;87(1):334-343. doi: 10.1007/s12020-024-04043-4. Epub 2024 Sep 25.
4
Physiological and pathophysiological actions of insulin in the liver.胰岛素在肝脏中的生理及病理生理作用。
Endocr J. 2025 Feb 3;72(2):149-159. doi: 10.1507/endocrj.EJ24-0192. Epub 2024 Sep 3.
5
High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region.肝癌及癌旁组织配对临床样本的高分辨魔角旋转核磁共振波谱分析。
Int J Mol Sci. 2024 Aug 16;25(16):8924. doi: 10.3390/ijms25168924.
6
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).肥胖与慢性炎症在代谢功能紊乱表现中的分子和病理生理学关系及其炎症介导的治疗选择(综述)。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12.
7
Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks.代谢相关脂肪性肝病与胰岛素抵抗:复杂关联综述
Metabolites. 2023 Jun 15;13(6):757. doi: 10.3390/metabo13060757.
8
Targeted Delivery of Butyrate Improves Glucose Homeostasis, Reduces Hepatic Lipid Accumulation and Inflammation in db/db Mice.丁酸盐靶向递送改善 db/db 小鼠的葡萄糖稳态,减少肝脏脂质蓄积和炎症。
Int J Mol Sci. 2023 Feb 25;24(5):4533. doi: 10.3390/ijms24054533.
9
Insulin sensitivity is associated with the observed variation of de novo lipid synthesis and body composition in finishing pigs.胰岛素敏感性与育肥猪中新合成脂质和体成分的观察到的变化有关。
Sci Rep. 2022 Aug 26;12(1):14586. doi: 10.1038/s41598-022-18799-0.
10
Iron Overload and the Risk of Diabetes in the General Population: Results of the Chinese Health and Nutrition Survey Cohort Study.铁过载与普通人群糖尿病风险:中国健康与营养调查队列研究的结果。
Diabetes Metab J. 2022 Mar;46(2):307-318. doi: 10.4093/dmj.2020.0287. Epub 2022 Mar 7.
脂肪酸对肝脏基因转录的调控。
J Nutr. 2005 Nov;135(11):2503-6. doi: 10.1093/jn/135.11.2503.
4
A high-cholesterol, n-3 polyunsaturated fatty acid diet causes different responses in rats and hamsters.高胆固醇、n-3多不饱和脂肪酸饮食在大鼠和仓鼠中会引发不同的反应。
Ann Nutr Metab. 2005 Nov-Dec;49(6):386-91. doi: 10.1159/000088891. Epub 2005 Oct 11.
5
Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.多不饱和脂肪酸通过抑制ChREBP核蛋白易位来抑制糖酵解和脂肪生成基因。
J Clin Invest. 2005 Oct;115(10):2843-54. doi: 10.1172/JCI25256. Epub 2005 Sep 22.
6
Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha.肝脏过氧化物酶体脂肪酸β-氧化受肝脏X受体α调控。
Endocrinology. 2005 Dec;146(12):5380-7. doi: 10.1210/en.2005-0591. Epub 2005 Aug 25.
7
Regulation of blood glucose by hypothalamic pyruvate metabolism.下丘脑丙酮酸代谢对血糖的调节
Science. 2005 Aug 5;309(5736):943-7. doi: 10.1126/science.1112085.
8
Insulin acutely decreases hepatic fatty acid synthase activity.胰岛素可迅速降低肝脏脂肪酸合酶的活性。
Cell Metab. 2005 Jul;2(1):43-53. doi: 10.1016/j.cmet.2005.06.001.
9
"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.“新生”肝脂肪激活过氧化物酶体增殖物激活受体α(PPARα)以维持葡萄糖、脂质和胆固醇的稳态。
Cell Metab. 2005 May;1(5):309-22. doi: 10.1016/j.cmet.2005.04.002.
10
LXRs regulate the balance between fat storage and oxidation.肝脏X受体调节脂肪储存与氧化之间的平衡。
Cell Metab. 2005 Apr;1(4):231-44. doi: 10.1016/j.cmet.2005.03.001.